Current endoscopic therapy of variceal bleeding

Best Practice and Research: Clinical Gastroenterology

Volumn 22, Issue 2, 2008, Pages 261-278

  Villanueva, Càndid ^b   Colomo, Alan ^a   Aracil, Carlos ^a   Guarner, Carlos ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b NONE

Author keywords

endoscopic therapy; endoscopic variceal ligation; portal hypertension; sclerotherapy; variceal bleeding

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEFTRIAXONE; ISOSORBIDE MONONITRATE; LACTITOL; LACTULOSE; MONOETHANOLAMINE OLEATE; MORRHUATE SODIUM; NITRATE; NORFLOXACIN; OCTREOTIDE; POLIDOCANOL; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SCLEROSING AGENT; SOMATOSTATIN; TERLIPRESSIN; TETRADECYL SULFATE SODIUM; VASOACTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ARGON PLASMA COAGULATION; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; ESOPHAGOSCOPY; ESOPHAGUS VARICES BLEEDING; EVIDENCE BASED MEDICINE; HEMODYNAMIC MONITORING; HEMOSTASIS; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MONOTHERAPY; MORTALITY; PATHOPHYSIOLOGY; PATIENT SAFETY; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; RECURRENT DISEASE; RISK REDUCTION; STOMACH HEMORRHAGE; STOMACH VARICES; SURVIVAL RATE; UNSPECIFIED SIDE EFFECT; VEIN LIGATION;

ADRENERGIC BETA-ANTAGONISTS; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; HEMOSTASIS, ENDOSCOPIC; HUMANS; ISOSORBIDE; LIGATION; LYSINE VASOPRESSIN; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RECURRENCE; SOMATOSTATIN; TISSUE ADHESIVES;

EID: 40749144903     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2007.11.012     Document Type: Article

References (100)

1. D'Amico G., De Franchis R., and Cooperative Study group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38 (2003) 599-612
2. Chalasani N., Kahi C., Francois F., et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 98 (2003) 653-659
3. Carbonell N., Pauwels A., Serfaty L., et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40 (2004) 652-659
4. D'Amico G., Pagliaro L., and Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 19 (1999) 475-505
5. De Franchis R., and Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 5 (2001) 645-663
6. Groszmann R.J., Garcia-Tsao G., Bosch J., et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 353 (2005) 2254-2261
7. North Italian Endoscopic Club for the study and treatment of esophageal varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 319 (1988) 983-989
8. Bosch J., Abraldes J.G., and Groszmann R. Current management of portal hypertension. J Hepatol 38 (2003) S54-S68
9. Lebrec D., De Fleury P., Rueff B., et al. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 79 (1980) 1139-1144
10. Garcia-Tsao G., Groszmann R.J., Fisher R.L., et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 5 (1985) 419-424
11. Ripoll C., Groszmann R., Garcia-Tsao G., et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 133 (2007) 481-488
12. Polio J., and Groszmann R.J. Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment. Semin Liver Dis 6 (1986) 318-331
13. Groszmann R.J., Bosch J., Grace N.D., et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 99 (1990) 1401-1407
14. Feu F., García-Pagán J.C., Bosch J., et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 346 (1995) 1056-1059
15. Vianna A., Hayes P.C., Moscoso G., et al. Normal venous circulation of gastroesophageal junction. A route to understanding varices. Gastroenterology 93 (1987) 876-879
16. Escorsell A., and Bosch J. Pathophysiology of variceal rupture. In: Groszmann R.J., and Bosch J. (Eds). Portal Hypertension in the 21st Century (2004), Kluwer Academic Publishers, Dordrecht 155-166
17. De Franchis R., and Primignani M. Endoscopic treatments for portal hypertension. Semin Liver Dis 19 (1999) 439-455
18. Villanueva C., Sancho-Poch F.J., Balanzó J., et al. Esophagic histopathologic changes induced by variceal sclerosing therapy. Gastroenterol Hepatol 13 (1990) 15-19
19. Stiegmann G.V., Sun J.H., and Hammond W.S. Results of experimental endoscopic esophageal varix ligation. Am Surg 54 (1988) 105-108
20. Baillie J., and Yudelman P. Complications of endoscopic sclerotherapy of esophageal varices. Endoscopy 24 (1992) 284-291
21. Schuman B.M., Beckman J.W., Tedesco F.J., et al. Complications of endoscopic injection sclerotherapy: a review. Am J Gastroenterol 82 (1987) 823-830
22. Stiegmann G.V., Goff J.S., Michaletz-Onody P.A., et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 326 (1992) 1527-1532
23. Laine L., and Cook D. Endoscopic ligation compared with sclerothepary for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 123 (1995) 280-287
24. Aracil C., Monfort D., Piqueras M., et al. Influence of spontaneous hemodynamic response on the efficacy of endoscopic therapy to prevent variceal rebleeding [abstract]. J Hepatol 42 Suppl 2 (2005) 76
25. Villanueva C., Miñana J., Ortiz J., et al. Endoscopic ligation compared with combined treatment with nadolol plus isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 345 (2001) 647-655
26. Westaby D. Emergency and elective endoscopic therapy for variceal hemorrhage. Baillière's Clin Gastroenterol 6 (1992) 465-480
27. Helmy A., and Hayes P.C. Current endoscopic therapeutic options in the management of variceal bleeding. Aliment Pharmacol Ther 15 (2001) 575-594
28. Gostout C.J. Endoscopic esophageal variceal band ligation: How intensively should we ligate?. Am J Gastroenterol (1998) 93135-93137
29. Cipolletta L., Bianco M.A., Rotondano G., et al. Argon plasma coagulation prevents variceal recurrence after band ligation of esophageal varices: preliminary results of a prospective randomized trial. Gastrointest Endosc 56 (2002) 467-471
30. Shaheen N.J., Stuart E., Schmitz S.M., et al. Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology 41 (2005) 588-594
31. García-Pagán J.C., and Bosch J. Endoscopic band ligation in the treatment of portal hypertension. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 526-535
32. Burroughs A.K., and Patch D. Management of variceal hemorrhage in cirrhotic patients. Gut 48 (2001) 738-740
33. De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43 (2005) 167-176
34. Garcia-Tsao G., Sanyal A., Grace N.D., et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 46 (2007) 922-938
35. Bernard B., Grange J.D., Khac E.N., et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 29 (1999) 1655-1661
36. Hou M.C., Lin H.C., Liu T.T., et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 39 (2004) 746-753
37. Soriano G., Guarner C., Tomás A., et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 103 (1992) 1267-1272
38. Fernández J., Ruiz del Arbol L., Gómez C., et al. Norfloxacin vs Ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 131 (2006) 1049-1056
39. Levacher S., Letoumelin P., Pateron D., et al. Early administration of terlipressin plus glyceryl trinatre to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 346 (1995) 865-868
40. Avgerinos A., Nevens F., Raptis S., et al. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet 350 (1997) 1495-1499
41. Calés P., Masliah C., Bernard B., et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 334 (2001) 23-28
42. Feu F., Ruiz del Arbol L., Bañares R., et al. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Gastroenterology 111 (1996) 1291-1299
43. Corley D.A., Cello J.P., Adkinsson W., et al. Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology 120 (2001) 946-954
44. D'Amico G., Pietrosi G., Tarantino I., et al. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 124 (2003) 1277-1291
45. Villanueva C., Ortiz J., Sàbat M., et al. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Hepatology 30 (1999) 384-389
46. Lo G.H., Lai K.H., Cheng J.S., et al. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology 25 (1997) 1101-1104
47. Jensen D.M., Kovacs T.O.G., Randall G., et al. Emergency sclerotherapy vs. rubber band ligation for actively bleeding esophageal varices in a randomized prospective study [abstract]. Gastrointest Endosc 40 (1994) 241
48. Laine L. Ligation: endoscopic treatment of choice for patients with bleeding esophageal varices. Hepatology 22 (1995) 663-665
49. Sung J.K., Chung S.C., Yung M.Y., et al. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 346 (1995) 1666-1669
50. Shields R., Jenkins S.A., Baxter J.N., et al. A prospective randomized controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control oesophageal varices. J Hepatol 16 (1992) 128-137
51. Villanueva C., Piqueras M., Aracil C., et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol 45 (2006) 560-567
52. Avgerinos A., Armonis A., Stefanidis G., et al. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology 39 (2004) 1623-1630
53. Ready J.B., Robertson A.D., Goff J.S., et al. Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure. Gastroenterology 100 (1991) 1403-1410
54. Moitinho E., Escorsell A., Bandi J.C., et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117 (1999) 626-631
55. Villanueva C., Ortiz J., Miñana J., et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology 121 (2001) 110-117
56. Bañares R., Albillos A., Rincón D., et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 35 (2002) 609-615
57. Burroughs A.K., and Patch D. Transjugular intrahepatic portosystemic shunt. Semin Liver Dis 19 (1999) 457-473
58. Bosch J. Salvage transjugular intrahepatic portosystemic shunt: is it really life-saving?. J Hepatol 35 (2001) 658-660
59. Burroughs A.K., Hamilton G., Phillips A., et al. A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med 321 (1989) 857-862
60. Villanueva C., Planella M., Aracil C., et al. Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in non-responders to the usual somatostatin dose. Am J Gastroenterol 100 (2005) 624-630
61. Moitinho E., Planas R., Bañares R., et al. Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding. J Hepatol 35 (2001) 712-718
62. Monescillo A., Martínez-Lagares F., Ruiz-del-Arbol L., et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40 (2004) 793-801
63. Bosch J., Thabut D., Bendtsen F., et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127 (2004) 1123-1130
64. Bosch J., and García-Pagán J.C. Prevention of variceal rebleeding. Lancet 361 (2003) 952-954
65. Bernard B., Lebrec D., Mathurin P., et al. Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. J Hepatol 26 (1997) 312-324
66. Laine L., Stein C., and Sharma V. Randomized comparison of ligation plus sclerotherapy in patients with bleeding esophageal varices. Gastroenterology 110 (1996) 529-533
67. Singh P., Pooran N., Indaram A., et al. Combined ligation and sclerotherapy versus ligation alone for secondary prophylaxis of esophageal variceal bleeding: a meta-analysis. Am J Gastroenterol 97 (2002) 623-629
68. Karsan H.A., Morton S.C., Shekelle P.G., et al. Combination endoscopic band ligation and sclerotherapy compared with endoscopic band ligation alone for the secondary prophylaxis of esophageal variceal hemorrhage: a meta-analysis. Dig Dis Sci 50 (2005) 399-406
69. Garcia-Pagán J.C., Feu F., Bosch J., et al. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study. Ann Intern Med 114 (1991) 869-873
70. Gournay J., Masliah C., Martin T., et al. Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding. Hepatology 31 (2000) 1239-1245
71. Villanueva C., Balanzó J., Novella M., et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 334 (1996) 1624-1629
72. D'Amico G., Garcia-Pagan J.C., Luca A., et al. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 131 (2006) 1611-1624
73. Abraldes J.G., Tarantino I., Turnes J., et al. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 37 (2003) 902-908
74. Villanueva C., López-Balaguer J.M., Aracil C., et al. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. J Hepatol 40 (2004) 757-765
75. Villanueva C., Aracil C., and Balanzó J. What to do with non-responders. In: Groszmann R.J., and Bosch J. (Eds). Portal Hypertension in the 21st Century (2004), Kluwer Academic Publishers, Dordrecht 337-348
76. Patch D., Sabin C.A., Goulis J., et al. A randomized controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 123 (2002) 1013-1019
77. Lo G.H., Chen W.C., Chen M.H., et al. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal bleeding. Gastroenterology 123 (2002) 728-734
78. Romero G., Kravetz D., Argonz J., et al. Comparative study between nadolol and 5-isosorbide mononitrate vs endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Aliment Pharmacol Ther 24 (2006) 601-611
79. Lo G.H., Lai K.H., Cheng J.S., et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 32 (2000) 461-565
80. De la Peña J., Brullet E., Sanchez-Hernández E., et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 41 (2005) 572-578
81. García-Pagán J.C., Villanueva C., Albillos A., et al. Nadolol + Isosorbide-5-mononitrate (NAD + ISMN) vs NAD + ISMN+ endoscopic band ligation in the prevention of rebleeding in patients with cirrhosis: preliminary results of a multicenter RCT [abstract]. J Hepatol 44 Suppl 2 (2006) S11-S12
82. Bureau C., Péron J.M., Alric L., et al. 'A la carte' treatment of portal hypertension: adapting therapy to hemodynamic response for the prevention of bleeding. Hepatology 36 (2002) 1361-1366
83. Gonzalez A., Agustin S., Perez M., et al. Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study. Hepatology 44 (2006) 806-812
84. Papatheodoridis G.V., Goulis J., Leandro G., et al. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology 30 (1999) 612-622
85. Luca A., D'Amico G., La Galla R., et al. TIPS for prevention of recurrent bleeding in patients with cirrhosis: a meta-analysis of randomized clinical trials. Radiology 212 (1999) 411-421
86. Escorsell A., Bañares R., García-Pagán J.C., et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 35 (2002) 385-392
87. Bernard-Chabert B., Sauerbruch T., Lo G.H., et al. Prevention of rebleeding. In: De Franchis R. (Ed). Portal Hypertension IV. Proceedings of the fourth Baveno international consensus workshop on methodology of diagnosis and treatment (2006), Blackwell, Oxford UK 262-284
88. Henderson J.M., Boyer T.D., Kutner M.H., et al. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 130 (2006) 1643-1651
89. Lebrec D., Nouel O., Corbic M., et al. Propranolol - a medical treatment for portal hypertension?. Lancet 2 (1980) 180-182
90. Poynard T., Calès P., Pasta L., et al. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices: an analysis of data and prognostic factors in 589 patients from four randomized clinical trials. N Engl J Med 324 (1991) 1532-1538
91. Imperiale T.F., and Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 33 (2001) 802-807
92. Khuroo M.S., Khuroo N.S., Farahat K.L., et al. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 21 (2005) 347-361 89
93. Sarin S.K., Wadhawan M., Agarwal S.R., et al. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol 100 (2005) 797-804
94. García-Pagán J.C., Villanueva C., Vila M.C., et al. Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers. Gastroenterology 121 (2001) 908-914
95. Turnes J., Garcia-Pagan J.C., Abraldes J.G., et al. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol 101 (2006) 506-512
96. Aracil C., Colomo A., Ordas I., et al. Acute hemodynamic response to beta-blockers for the prediction of long-term outcome in primary prophylaxis of variceal bleeding. Final results of a prospective study [abstract]. J Hepatol 46 Suppl 1 (2007) S35
97. Merkel C., Marin R., Angeli P., et al. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 127 (2004) 476-484
98. Sarin S.K. Gastric varices. In: Groszmann R.J., and Bosch J. (Eds). Portal Hypertension in the 21st Century (2004), Kluwer Academic Publishers, Dordrecht 277-300
99. Lo G.H., Lai K.H., Cheng J.S., et al. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 33 (2001) 1060-1064
100. Tan P.C., Hou M.C., Lin H.C., et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology 43 (2006) 690-697